Matches in SemOpenAlex for { <https://semopenalex.org/work/W2977885589> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W2977885589 endingPage "35" @default.
- W2977885589 startingPage "30" @default.
- W2977885589 abstract "Aim. To assess the effectiveness of long-term treatment with magnesium orotate (Magnerot®), as a pathogenetic therapy, in patients with mitral valve prolapse (MVP). Material and methods. In total, 31 MVP patients, administered Magnerot® (1500 mg/d) in three-month courses, twice a year, were followed up for 15 years. All patients underwent a complex clinical and instrumental examination which included clinical assessment, M-mode and B-mode echocardiography with simultaneous electrocardiography (ECG), standard 12-lead ECG at rest, 24-hour ECG monitoring, 24-hour blood pressure monitoring (BPM), and heart rate variability (HRV) assessment. Results. The study identified the specifics of clinical features, their association with the degree of phenotypical manifestation of connective tissue dysplasia, ECG changes, heart valve structure, autonomic homeostasis, BP levels and circadian profile, and sympathetic and parasympathetic tone. There was a significant reduction in mean and maximal heart rate, the number of tachycardia episodes, QTc interval duration, as well as the incidence of paroxysmal supraventricular tachycardia, supraventricular and ventricular extrasystolia. Maximal systolic and diastolic BP (SBP, DBP) levels, BP load, and initially increased SBP and DBP variability were significantly reduced. The retrospective analysis results showed a normalisation of the above-mentioned parameters in all participants. The sympathetic tone decreased, as demonstrated by a twofold reduction in the number of patients with sympathicotonia, a threefold increase in the number of participants with vagotonia, and a five-fold increase in the number of individuals with balanced sympathetic and parasympathetic tone. Conclusion. One-half of the examined MVP patients, who were administered a long-term Magnerot® therapy, have demonstrated a significant improvement in the treatment effectiveness index." @default.
- W2977885589 created "2019-10-10" @default.
- W2977885589 creator A5024695173 @default.
- W2977885589 creator A5081499558 @default.
- W2977885589 creator A5090093846 @default.
- W2977885589 date "2012-06-20" @default.
- W2977885589 modified "2023-10-12" @default.
- W2977885589 title "Long-term magnesium orotate therapy in patients with mitral valve prolapse" @default.
- W2977885589 cites W1863495712 @default.
- W2977885589 cites W2088977510 @default.
- W2977885589 cites W2161745189 @default.
- W2977885589 cites W2210311182 @default.
- W2977885589 cites W2341046026 @default.
- W2977885589 doi "https://doi.org/10.15829/1728-8800-2012-3-30-35" @default.
- W2977885589 hasPublicationYear "2012" @default.
- W2977885589 type Work @default.
- W2977885589 sameAs 2977885589 @default.
- W2977885589 citedByCount "1" @default.
- W2977885589 countsByYear W29778855892022 @default.
- W2977885589 crossrefType "journal-article" @default.
- W2977885589 hasAuthorship W2977885589A5024695173 @default.
- W2977885589 hasAuthorship W2977885589A5081499558 @default.
- W2977885589 hasAuthorship W2977885589A5090093846 @default.
- W2977885589 hasBestOaLocation W29778855891 @default.
- W2977885589 hasConcept C118441451 @default.
- W2977885589 hasConcept C126322002 @default.
- W2977885589 hasConcept C164705383 @default.
- W2977885589 hasConcept C2776934708 @default.
- W2977885589 hasConcept C2777543888 @default.
- W2977885589 hasConcept C2777953023 @default.
- W2977885589 hasConcept C2779161974 @default.
- W2977885589 hasConcept C2780040984 @default.
- W2977885589 hasConcept C2780283014 @default.
- W2977885589 hasConcept C2781030672 @default.
- W2977885589 hasConcept C2910597771 @default.
- W2977885589 hasConcept C57900726 @default.
- W2977885589 hasConcept C71635504 @default.
- W2977885589 hasConcept C71924100 @default.
- W2977885589 hasConcept C84393581 @default.
- W2977885589 hasConceptScore W2977885589C118441451 @default.
- W2977885589 hasConceptScore W2977885589C126322002 @default.
- W2977885589 hasConceptScore W2977885589C164705383 @default.
- W2977885589 hasConceptScore W2977885589C2776934708 @default.
- W2977885589 hasConceptScore W2977885589C2777543888 @default.
- W2977885589 hasConceptScore W2977885589C2777953023 @default.
- W2977885589 hasConceptScore W2977885589C2779161974 @default.
- W2977885589 hasConceptScore W2977885589C2780040984 @default.
- W2977885589 hasConceptScore W2977885589C2780283014 @default.
- W2977885589 hasConceptScore W2977885589C2781030672 @default.
- W2977885589 hasConceptScore W2977885589C2910597771 @default.
- W2977885589 hasConceptScore W2977885589C57900726 @default.
- W2977885589 hasConceptScore W2977885589C71635504 @default.
- W2977885589 hasConceptScore W2977885589C71924100 @default.
- W2977885589 hasConceptScore W2977885589C84393581 @default.
- W2977885589 hasIssue "3" @default.
- W2977885589 hasLocation W29778855891 @default.
- W2977885589 hasLocation W29778855892 @default.
- W2977885589 hasOpenAccess W2977885589 @default.
- W2977885589 hasPrimaryLocation W29778855891 @default.
- W2977885589 hasRelatedWork W1998201413 @default.
- W2977885589 hasRelatedWork W2020726715 @default.
- W2977885589 hasRelatedWork W2031104701 @default.
- W2977885589 hasRelatedWork W2047828183 @default.
- W2977885589 hasRelatedWork W2114922413 @default.
- W2977885589 hasRelatedWork W2170445507 @default.
- W2977885589 hasRelatedWork W2317369825 @default.
- W2977885589 hasRelatedWork W2377867082 @default.
- W2977885589 hasRelatedWork W2977885589 @default.
- W2977885589 hasRelatedWork W348908434 @default.
- W2977885589 hasVolume "11" @default.
- W2977885589 isParatext "false" @default.
- W2977885589 isRetracted "false" @default.
- W2977885589 magId "2977885589" @default.
- W2977885589 workType "article" @default.